Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Badger vaccination suspended in Wales
badger
Production of the Badger BCG vaccine has been halted until further notice.
Global shortage of BCG vaccine prompts usage review

The Welsh Government has suspended its badger vaccination project for 2016 due to a global shortage of the BCG vaccine.

In response to the shortage, the World Health Organisation is urging all countries to review their BCG usage, to ensure the countries with the highest rates of human TB take priority.

SSI, the company that produces Badger BCG, says it will not produce any more until further notice, due to a backlog in production of the human vaccine.

If Wales were to continue its badger vaccination programme, it would have to source human BCG for use on badgers.

In light of the global shortage and that fact that one badger vaccine equals 10 human adult doses or 20 human infant doses, the government has decided to suspend the project until the vaccine supply for humans is adequate.

President of BVA's Welsh branch, Neil Paton, said: "This is disappointing news and will be a significant blow to the bovine tuberculosis (bTB) eradication programme in Wales. However, it is clear that the One Health and human health agenda should take priority in this case.
 
"We urge Welsh Government to reconsider its eradication programme as a matter of urgency, particularly in relation to wildlife control."

Wales is four years into a five-year vaccination programme in the intensive action area (IAA) and two years into private vaccination grants. However, the Welsh deputy minister for farming and food, Rebecca Evans, said "this does not mean that the hard work of the previous years will have been wasted".

She continued: "Vaccination is far from the only tool in our armoury in our efforts to eradicate bovine TB. We have increased focus on epidemiology and are identifying patterns of disease in Wales.

"We have developed a TB dashboard to present TB data clearly, introduced informed purchasing polices, and are monitoring the profile of disease in wildlife through our Badger Found Dead survey."

Modelling work has also been commissioned to investigate the potential impact of the changes on the IAA vaccination project.

 

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.